1,411 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
NVS Novartis AG $85.13 $197.65B N/A
Article Searches
J&J (JNJ) Anaemia Drug Marketing Label Expanded in Europe http://www.zacks.com/stock/news/254220/jj-jnj-anaemia-drug-marketing-label-expanded-in-europe?cid=CS-ZC-FT-254220 Mar 27, 2017 - Johnson & Johnson (JNJ) announced that the French health authority has granted approval to expand the label of Eprex to include treatment of symptomatic anaemia in patients with low or intermediate risk myelodysplastic syndromes (MDS).
TiGenix NV (ADS) (TIG) Presents At Deutsche Bank Depositary Receipts Virtual Investor Conference - Slideshow https://seekingalpha.com/article/4057764-tigenix-nv-ads-tig-presents-deutsche-bank-depositary-receipts-virtual-investor-conference?source=feed_sector_healthcare Mar 24, 2017 - The following slide deck was published by TiGenix NV (NYSE:ADS) in conjunction with this event.
The Zacks Analyst Blog Highlights: Milacron Holdings, Galapagos NV and Raymond James Financial http://www.zacks.com/stock/news/254054/the-zacks-analyst-blog-highlights-milacron-holdings-galapagos-nv-and-raymond-james-financial?cid=CS-ZC-FT-254054 Mar 24, 2017 - The Zacks Analyst Blog Highlights: Milacron Holdings, Galapagos NV and Raymond James Financial
Pharma Stock Roundup: Is Sanofi Buying Flexion? Pfizer, Merck KGaA Drug Approved http://www.zacks.com/stock/news/253983/pharma-stock-roundup-is-sanofi-buying-flexion-pfizer-merck-kgaa-drug-approved?cid=CS-ZC-FT-253983 Mar 24, 2017 - This week's highlights include rumors regarding Sanofi (SNY) acquiring Flexion, accelerated FDA approval for a Pfizer/Merck KGaA drug and drug pricing.
AVEO (AVEO) Reports Narrower-than-Expected Loss in Q4 http://www.zacks.com/stock/news/253920/aveo-aveo-reports-narrower-than-expected-loss-in-q4?cid=CS-ZC-FT-253920 Mar 23, 2017 - AVEO Pharmaceuticals, Inc. (AVEO) reported a narrower-than-expected loss in the fourth-quarter 2016.
Bain Capital Investors Llc Buys Frank's International NV, Sells Veritiv http://www.gurufocus.com/news/494454/bain-capital-investors-llc-buys-franks-international-nv-sells-veritiv Mar 22, 2017 - Bain Capital Investors Llc Buys Frank's International NV, Sells Veritiv, Stocks: FI,VRTV,, release date:Mar 22, 2017
Novartis' Acute Heart Failure Drug Fails in Late-Stage Study http://www.zacks.com/stock/news/253764/novartis-acute-heart-failure-drug-fails-in-late-stage-study?cid=CS-ZC-FT-253764 Mar 22, 2017 - Novartis AG (NVS) recently suffered a setback on the announcement of disappointing data from a phase III study, RELAX-AHF-2, on pipeline candidate serelaxin (RLX030).
Uniqure NV (QURE) Presents At Oppenheimer 27th Annual Healthcare Conference - Slideshow http://seekingalpha.com/article/4057235-uniqure-nv-qure-presents-oppenheimer-27th-annual-healthcare-conference-slideshow?source=feed_sector_healthcare Mar 22, 2017 - The following slide deck was published by uniQure N.V. in conjunction with this event.
Array BioPharma's NDA for Cancer Drug Withdrawn; Shares Down http://www.zacks.com/stock/news/253718/array-biopharmas-nda-for-cancer-drug-withdrawn-shares-down?cid=CS-ZC-FT-253718 Mar 22, 2017 - Shares of Array BioPharma Inc. (ARRY) slipped 2.30% after the company announced that it has withdrawn its new drug application (NDA) for its pipeline candidate, binimetinib, from the FDA's Division of Oncology Products 2.
Does Novartis (NVS) Stock Make a Good Value Pick? http://www.zacks.com/stock/news/253533/does-novartis-nvs-stock-make-a-good-value-pick?cid=CS-ZC-FT-253533 Mar 21, 2017 - Let's see if Novartis AG (NVS) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
<<<Page 131>